Gritstone bio, Inc. (GRTS)

Gritstone bio Income Statement

Financials in millions USD. Fiscal year is January - December.

Year Ending	TTM	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020	Dec 31, 2019
Revenue	15.65	16.34	19.95	48.21	4.04	4.37
Revenue Growth (YoY)	2.95%	-18.05%	-58.63%	1094.30%	-7.51%	267.73%
Gross Profit	15.65	16.34	19.95	48.21	4.04	4.37
Selling, General & Admin	30.54	28.78	28.97	25.93	21.41	19.41
Research & Development	129.71	127.18	111.4	97.49	88.64	82.9
Other Operating Expenses	0.03	0.03	0	0	0	0
Operating Expenses	160.28	156	140.37	123.42	110.05	102.31
Operating Income	-144.64	-139.65	-120.43	-75.21	-106.02	-97.94
Interest Expense / Income	4.49	4.04	1.24	0.04	0.01	0
Other Expense / Income	-4.23	-5.2	-1.98	-0.16	-0.72	-3.51
Pretax Income	-144.89	-138.49	-119.69	-75.08	-105.31	-94.43
Net Income	-144.89	-138.49	-119.69	-75.08	-105.31	-94.43
Shares Outstanding (Basic)	118	116	91	79	38	34
Shares Outstanding (Diluted)	118	116	91	79	38	34
Shares Change	3.47%	27.07%	15.25%	108.73%	12.63%	276.21%
EPS (Basic)	-1.24	-1.20	-1.32	-0.95	-2.79	-2.81
EPS (Diluted)	-1.24	-1.20	-1.32	-0.95	-2.79	-2.81
Free Cash Flow	-118.27	-126.22	-121.82	-56.38	-92.62	-101.18
Free Cash Flow Per Share	-1.00	-1.09	-1.34	-0.71	-2.45	-3.02
Gross Margin	100.00%	100.00%	100.00%	100.00%	100.00%	100.00%
Operating Margin	-924.49%	-854.46%	-603.80%	-155.99%	-2626.13%	-2243.76%
Profit Margin	-926.13%	-847.34%	-600.09%	-155.73%	-2608.72%	-2163.41%
Free Cash Flow Margin	-755.98%	-772.27%	-610.77%	-116.93%	-2294.20%	-2318.08%
EBITDA	-117.74	-112.8	-102.76	-60.65	-91.15	-83.31
EBITDA Margin	-752.58%	-690.16%	-515.22%	-125.79%	-2257.79%	-1908.50%
Depreciation & Amortization	22.66	21.65	15.69	14.4	14.16	11.13
EBIT	-140.4	-134.45	-118.45	-75.05	-105.3	-94.43
EBIT Margin	-897.43%	-822.65%	-593.89%	-155.65%	-2608.42%	-2163.41%

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).